bibliographic entry 1561772 [be/1561772]
https://w3id.org/oc/corpus/be/1561772

is a
content
  • Park, S, Chung, MJ, Park, JY. Phase II trial of erlotinib plus gemcitabine chemotherapy in Korean patients with advanced pancreatic cancer and prognostic factors for chemotherapeutic response, Gut Liver, 2013, 7, 611, 615, DOI: 10.5009/gnl.2013.7.5.611, PMID: 24073321
references